Schwartz D D, Naff B P
Department of Physiology and Pharmacology, Auburn University, AL 36849, USA.
J Cardiovasc Pharmacol. 1997 Feb;29(2):257-64. doi: 10.1097/00005344-199702000-00015.
Cardiac beta-adrenergic receptors are the primary driving force for the enhancement of contractility in response to sympathetic stimulation. Angiotensin II influences cardiac function by modulating sympathetic activity and by activating cardiac angiotensin II receptors. The aim of this study was to determine whether activation of cardiac angiotensin II receptors modulates the responsiveness of the heart to beta-adrenergic receptor activation. Male Sprague-Dawley rats were anesthetized and the hearts isolated and perfused with oxygenated Krebs-Henseleit buffer (KHB). Coronary artery perfusion pressure, left ventricular pressure (LVP), left ventricular dP/dtmax, and heart rate (HR) were measured. Bolus administration of the beta-adrenergic receptor agonists, isoproterenol, dobutamine, and salbutamol, produced dose-related increases in LVP, LV dP/dt(max), and HR. Addition of angiotensin-II (10-100 nM) to the KHB slightly increased coronary perfusion pressure but did not alter baseline LVP, LV dP/dt(max), or HR. Angiotensin II reduced the increase in LVP, LV dP/dt(max), and HR elicited by isoproterenol and dobutamine but did not affect responses to salbutamol. The inhibitory effect of angiotensin II was blocked by the AT1-receptor antagonist, losartan, and the protein kinase C inhibitor, calphostin C (50 nM). Activation of protein kinase C with phorbol-12, 13-dibutyrate (PDBu; 10 nM) reduced cardiac responses to all three agonists, although the effects were less on responses elicited by salbutamol. These data suggest that activation of protein kinase C by angiotensin II decreases the responsiveness of the rat heart to beta 1-adrenergic stimulation and that angiotensin II-mediated protein kinase C activation may differ from that activated by phorbol esters.
心脏β-肾上腺素能受体是响应交感神经刺激增强心肌收缩力的主要驱动力。血管紧张素II通过调节交感神经活性和激活心脏血管紧张素II受体来影响心脏功能。本研究的目的是确定心脏血管紧张素II受体的激活是否会调节心脏对β-肾上腺素能受体激活的反应性。将雄性Sprague-Dawley大鼠麻醉,分离心脏并用含氧的Krebs-Henseleit缓冲液(KHB)灌注。测量冠状动脉灌注压、左心室压力(LVP)、左心室dP/dtmax和心率(HR)。静脉注射β-肾上腺素能受体激动剂异丙肾上腺素、多巴酚丁胺和沙丁胺醇,可使LVP、LV dP/dt(max)和HR呈剂量依赖性增加。向KHB中添加血管紧张素II(10 - 100 nM)可使冠状动脉灌注压略有升高,但不改变基线LVP、LV dP/dt(max)或HR。血管紧张素II可减少异丙肾上腺素和多巴酚丁胺引起的LVP、LV dP/dt(max)和HR的增加,但不影响对沙丁胺醇的反应。血管紧张素II的抑制作用被AT1受体拮抗剂氯沙坦和蛋白激酶C抑制剂钙泊三醇C(50 nM)阻断。用佛波醇-12,13-二丁酸酯(PDBu;10 nM)激活蛋白激酶C可降低心脏对所有三种激动剂的反应,尽管对沙丁胺醇引起的反应影响较小。这些数据表明,血管紧张素II激活蛋白激酶C会降低大鼠心脏对β1-肾上腺素能刺激的反应性,并且血管紧张素II介导的蛋白激酶C激活可能与佛波酯激活的不同。